Pharmaceuticals
Eli Lilly Boosts Sales Forecast as Demand Soars for Weight-Loss Drug Zepbound
Increased Manufacturing Capacity to Address Shortages and Meet Skyrocketing Demand Eli Lilly & Co. (LLY) announced a significant increase in...
Morning Movers: Market Trends and Stocks to Watch
Stay Ahead of the Curve with Today's Top Market Insights and Key Stock Performances Koninklije Philips N.V (PHG) Philips announces...
FDA Approves Pfizer’s Beqvez Gene Therapy for Hemophilia B: A Milestone in Rare Disease Treatment
Pfizer's Breakthrough Therapy Offers Hope to Patients Despite Hefty Price Tag The Food and Drug Administration's approval of Pfizer's (PFE)...
Biodexa’s Acquisition of eRapa Marks Milestone in FAP Treatment Development
Strategic Agreement with Emtora Biosciences Propels Biodexa's Oncology Pipeline Forward with Potential to Transform Treatment Landscape Biodexa Pharmaceuticals PLC (BDRX)...
Merck’s Strong First Quarter Performance Sets Positive Tone Amidst Patent Expiration Preparations
Keytruda Sales Surge and Vaccine Demand Drive Revenue Growth, Signaling Resilience Amidst Looming Challenges Merck (MRK), the pharmaceutical giant, kicked...
Vanda Pharmaceuticals Rejects Unsolicited Acquisition Proposals from Future Pak
Board Determines Offers Undervalue Company's Robust Growth Prospects Vanda Pharmaceuticals (VNDA) has confirmed receiving multiple unsolicited acquisition proposals from Future...
Palisade Bio Reports Promising Results for UC Treatment PALI-2108
Successful Analysis Demonstrates Effective Bioactivation of Colon-Specific PDE4 Inhibitor Prodrug Palisade Bio (PALI), a biopharmaceutical firm dedicated to advancing therapies...
PaxMedica Completes Milestone for Suramin IV Formulation, Nears FDA Submission
Biopharmaceutical Company Advances Potential Treatment for Fatal Tropical Disease and Autism Spectrum Disorder PaxMedica (PXMD) has achieved a significant milestone...
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences in $4.9 Billion Deal
Acquisition Strengthens Vertex's Position in Immunotherapy and Renal Disease Treatment Vertex Pharmaceuticals (VRTX) and Alpine Immune Sciences, Inc. (Nasdaq: ALPN)...
Advancing Addiction Treatment: Adial Pharmaceuticals’ AD04 Shows Promise in Clinical Study
Peer-Reviewed Article Highlights Safety and Efficacy of Low-Dose Ondansetron in Treating Alcohol Use Disorder Adial Pharmaceuticals (ADIL), a pioneer in...
